Alterations of Bioactive Lipid Profiles in the Retina Following Traumatic Optic Neuropathy in Mice
Biomolecules · 2025
DOI: 10.3390/biom15101450 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, 2025. Verfasst von Min Young Kim und 6 weiteren Autor:innen. Beteiligte Einrichtung: Eye Research Center and Foundational Medical Studies, Oakland University William Beaumont School of Medicine (OUWB-SOM), Rochester, MI 48309, USA. Hauptthemen laut MEDLINE: Optic Nerve Injuries, Retina, Lipid Metabolism, Lipids. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NEI NIH HHS, NIH HHS, National Eye Institute.
Abstract (Originalsprache)
Traumatic optic neuropathy (TON) causes vision loss through compression and contusion, yet there is no consensus on the most effective treatment. Polyunsaturated fatty acid (PUFA)-derived bioactive lipids metabolized by lipoxygenase (LOX), cytochrome P450 (CYP), and cyclooxygenase (COX) enzymes are known mediators of inflammation and neurodegeneration. However, their role in TON-related retinal pathology remains unclear. Controlled orbital impact (COI) was used to induce unilateral TON in mice with controlled velocity (2–3 m/s), with the fellow eye serving as an internal control. Retina tissues were collected three days post-injury and analyzed by LC/MS to quantify bioactive lipid metabolites from ω−6 and ω−3 PUFAs. Statistical analysis was performed using paired, nonparametric Wilcoxon signed-rank tests with Benjamini–Hochberg false discovery rate (FDR) correction. Results showed that among 38 reliably detected metabolites, no individual lipid showed a statistically significant difference between TON and control eyes after FDR correction (q < 0.05). However, both individual and pathway-level analysis revealed consistent trends toward increased expression of LOX- and CYP-derived metabolites across FDA PUFA substrates, including arachidonic acid (AA), linoleic acid (LA), and docosahexaenoic acid (DHA). These findings support further investigation into lipid-mediated inflammation in TON and its potential as a therapeutic target, particularly through expanding both the sample size and the post-TON time periods.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Eye Research Center and Foundational Medical Studies, Oakland University William Beaumont School of Medicine (OUWB-SOM), Rochester, MI 48309, USA.
- Eye Research Institute, Oakland University, Rochester, MI 48309, USA.
- Department of Ophthalmology, Visual, and Anatomical Sciences, School of Medicine, Wayne State University, Detroit, MI 48201, USA.
- Department of Biochemistry, Faculty of Pharmacy, Mansoura University, Mansoura 35516, Egypt.
- Department of Pharmacology, School of Medicine, Wayne State University, Detroit, MI 48201, USA.
- Bioactive Lipids Research Program, Department of Pathology, Wayne State University School of Medicine, Detroit, MI 48202, USA.
ORCID-Profile: Min Young Kim, Nandini Koneru, Michael Risner, Ahmed S Ibrahim, Krishna Rao Maddipati, Mohamed Al-Shabrawey
Förderung
- NEI NIH HHS
- NIH HHS
- National Eye Institute
- NIH core
- National Institutes of Health
Zitieren
APA
Kim, M. Y., Koneru, N., Alahdab, G., Risner, M., Ibrahim, A. S., Maddipati, K. R., & Al-Shabrawey, M. (2025). Alterations of Bioactive Lipid Profiles in the Retina Following Traumatic Optic Neuropathy in Mice. Biomolecules. https://doi.org/10.3390/biom15101450
Vancouver
Kim MY, Koneru N, Alahdab G, Risner M, Ibrahim AS, Maddipati KR, et al. Alterations of Bioactive Lipid Profiles in the Retina Following Traumatic Optic Neuropathy in Mice. Biomolecules. 2025. doi:10.3390/biom15101450
BibTeX
@article{Kim2025,
author = {Kim, Min Young and Koneru, Nandini and Alahdab, Gieth and Risner, Michael and Ibrahim, Ahmed S and Maddipati, Krishna Rao and Al-Shabrawey, Mohamed},
title = {Alterations of Bioactive Lipid Profiles in the Retina Following Traumatic Optic Neuropathy in Mice},
journal = {Biomolecules},
year = {2025},
doi = {10.3390/biom15101450}
}
EUVIMED